Introduction
============

Traumatic renal injuries are comprised of a spectrum of parenchymal, vascular, and renal pelvic lacerations. An important aspect of renal trauma is the diagnosis and management of urinary extravasation. Urinary extravasation may be a relative indication for intervention and a reason for failure of conservative management after high-grade renal trauma (HGRT) ([@r1]). A timely and precise diagnosis of urinary extravasation, and proper intervention, can potentially minimize complications after HGRT.

The majority of renal trauma literature is focused on parenchymal lacerations and the risk of bleeding. Despite the importance of properly diagnosing urinary extravasation, very little is known about the true incidence of urinary extravasation after HGRT ([@r2]). It is believed that most cases of minor urinary extravasation will heal spontaneously; ureteral stenting is commonly used when an intervention is needed or if complications arise. However, the rates of stenting, as well as its indications, are also not well defined. We aimed to perform a review and pool data from the published literature, to examine the incidence of urinary extravasation after adult HGRT and also the rates of ureteral stenting in management of urinary extravasation.

Methods
=======

A scoping review design was used to map the existing literature and clarify concepts related to incidence and management of urinary extravasation using an a priori protocol to define our objectives and methods as previously described ([@r3]). Full details of the methods used are available as supplementary material.

Criteria for inclusion of studies were: adult renal trauma patients, studies published in 1989 or later \[after the publication of the current American Association for the Surgery of Trauma (AAST) grading system\], and quantification of number of patients with HGRT (using AAST grading or equivalents), number with urinary extravasation, and number who underwent ureteral stenting.

We used the AAST grading for classification of renal injuries ([@r4]). HGRT was defined as AAST grades III--V or equivalents if converting to AAST grading was possible. Similarly, grades III--V renal injuries according to the proposed revisions to the original AAST grading system were considered HGRT ([@r5]). We also converted the Japanese Association for the Surgery of Trauma (JAST) classifications to the corresponding AAST grades IV and V based on the scales suggested by Nishizawa *et al.* ([@r6]). We only calculated rates for ureteral stenting, because other procedures such as nephrostomy tube, peri-renal drain placement, and open surgeries were inconsistently reported, making it impossible to calculate meaningful intervention rates for these other procedures.

A sensitive search strategy was developed for Ovid Medline, peer-reviewed, then translated to Embase, CINAHL, and Cochrane Library databases. No language or study design filter was used. EndNote X7 software (Clarivate Analytics, Boston, MA, USA), was used to manage and deduplicate references.

Title, abstract and full-text screening were conducted independently by two reviewers with disagreements resolved by consensus or a third reviewer. A data extraction form was developed to collect the information including: full reference details, study design and duration, mechanism of trauma, total number of participants, number of patients with HGRT, grades of injury, number of patients with urinary extravasation, and number of patients treated with ureteral stenting. Data extraction was conducted by both reviewers.

Incidence of urinary extravasation was calculated based on the extracted values for each study. The rates of urinary extravasation were reported differently based upon studies' inclusion criteria and whether studies reported urinary extravasation rates in populations of grades III--V, IV-only, or IV--V. Separate and detailed rates were extracted from each study when the information was available. Rate of ureteral stenting was calculated in patients diagnosed with urinary extravasation. A meta-analysis of single sample binary proportions was performed using a random-effects model to pool the estimates and calculate confidence intervals (CIs) using STATA-15 statistical software (Stata corp., College Station, TX, USA).

Results
=======

[*Figure 1*](#f1){ref-type="fig"} shows the screening and study selection steps according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([@r7]). A total of 27 studies were included for full data extraction. Most studies were retrospective and mostly involved blunt renal trauma. Twenty-four studies contained information, which could be used to calculate urinary extravasation rates ([@r2],[@r6],[@r8]-[@r29]). A total of 20 studies contained enough information to calculate ureteral stenting rates for urinary extravasation ([@r2],[@r8],[@r9],[@r11]-[@r15],[@r18]-[@r21],[@r23]-[@r25],[@r29]-[@r33]). Three studies were only used to calculate stenting rates without containing information to calculate incidence of urinary extravasation ([@r30]-[@r32]).

![Screening and selection of articles (PRISMA flow diagram). PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses](tau-07-S2-S169-f1){#f1}

Incidence of urinary extravasation
----------------------------------

Of the 24 studies that were included for calculating urinary extravasation rates, only 4 were prospective ([@r8],[@r13],[@r20],[@r23]); three of them from the same center and with some overlap in data ([@r13],[@r20],[@r23]). Two of the 24 included studies, which met our inclusion criteria, are meeting abstracts with no published manuscript ([@r17],[@r24]). Seventeen studies included data on only blunt renal trauma, 6 on both blunt and penetrating injuries ([@r2],[@r8],[@r9],[@r11],[@r21],[@r28]), and 1 on penetrating injuries only ([@r17]) ([*Table 1*](#t1){ref-type="table"}).

###### Summary of studies reporting incidence of urinary extravasation after HGRT

  Author year                    Study period   Study site                               Grading system   Trauma mechanism   No. HGRT         No. urinary extravasation   \% of III--V    \% of IV--V     \% of IV        Note
  ------------------------------ -------------- ---------------------------------------- ---------------- ------------------ ---------------- --------------------------- --------------- --------------- --------------- ---------------------------------------------------------
  Keihani *et al.* 2018          2014--2017     Multi-institutional, USA                 AAST-NS          B & P              326 (III--V)     72                          22% (72/326)    NA              NA              Only patients with initial CT scans included
  Winters *et al.* 2016          1998--2010     Seattle, USA                             AAST-O           B & P              636 (III & IV)   95                          NA              NA              60% (95/159)    
  Takamatsu *et al.* 2016^a^     1982--2013     Yokohama, Japan                          JAST             B                  97 (IV & V)      35                          NA              36% (35/97)     NA              Japanese
  Shaaban *et al.* 2016          NS             Alexandria, Egypt                        AAST-R           B & P              37 (III--V)      16                          43% (16/37)     64% (16/25)     72% (16/22)     
  May *et al.* 2016              2004--2013     St. Louis, USA                           AAST-NS          B                  47 (IV & V)      3                           NA              6% (3/47)       NA              
  Lanchon *et al.* 2016          2004--2013     Grenoble, France                         AAST-O           B                  151 (IV & V)     96                          NA              66% (96/151)    NA              Overlap with long 2013
  Baghdanian *et al.* 2016       2006--2014     Boston, USA                              AAST-R           B                  103 (III--V)     22                          21% (22/103)    52% (22/42)     NA              
  Parkash *et al.* 2015          2008--2013     Nellore, India                           AAST-O           B                  16 (IV only)     15                          NA              NA              94% (15/16)     
  Maarouf *et al.* 2015          2007--2014     Riyadh, KSA                              AAST-O           B                  206 (III--V)     108                         52% (108/206)   87% (108/124)   NA              
  Fischer *et al.* 2015          2007--2013     Indianapolis, USA                        AAST-O           B & P              265 (III--V)     26                          10% (26/265)    27% (26/97)     26% (21/80)     Excretory phase not performed for all patients
  Darwish *et al.* 2015          2009--2013     St. Louis, USA                           AAST-NS          P                  41 (III--V)      11                          27% (11/41)     65% (11/17)     NA              Abstract only
  Malaeb *et al.* 2014           2003--2010     Seattle, USA                             AAST-R           B                  144 (IV only)    88                          NA              NA              61% (88/144)    Overlap with Winters 2016
  van der Wilden *et al.* 2013   2000--2011     Multi--institutional, New England, USA   AAST-O           B                  206 (IV & V)     60                          NA              29% (60/206)    NA              
  Long *et al.* 2013             2004--2011     Grenoble, France                         AAST-R           B                  99 (IV)          72                          NA              NA              73% (72/99)     Overlap with Lanchon 2016
  Hardee *et al.* 2013           2005--2011     Salt Lake City, USA                      AAST-R           B & P              126 (III--V)     18                          14% (18/126)    30% (18/61)     NA              
  Figler *et al.* 2013           2003--2010     Seattle, USA                             AAST-O           B                  84 (IV only)     79                          NA              NA              94% (79/84)     
  Fiard *et al.* 2012            2004--2010     Grenoble, France                         AAST-O           B                  88 (IV & V)      51                          NA              58% (51/88)     71% (51/71)     Overlap with Long 2013 and Lanchon 2016
  Smith *et al.* 2010            2003--2007     Seattle, USA                             AAST-O           B                  111 (IV & V)     81                          NA              73% (81/111)    74% (77/104)    Abstract only
  Nishizawa *et al.* 2009^a^     1991--2007     Wakayama, Japan                          JAST             B                  23 (IV & V)      8                           NA              35% (8/23)      NA              
  Malcolm *et al.* 2008          2002--2006     Memphis, USA                             AAST-O           B                  109 (III--V)     7                           6% (7/109)      25% (7/28)      27% (7/26)      
  Shinojima *et al.* 2004^a^     1982--1999     Yokohama, Japan                          JAST             B                  59 (IV & V)      21                          NA              36% (21/59)     NA              Japanese
  Bozeman *et al.* 2004          1993--2001     Shreveport, USA                          AAST-O           B                  26 (IV & V)      18                          NA              69% (18/26)     74% (14/19)     
  Hammer *et al.* 2003           1997--2001     Detroit, USA                             AAST-O           B & P              29 (III--V)      14                          48% (14/29)     NA              100% (14/14)    
  Matthews *et al.* 1997         1983--1997     Cleveland, USA                           AAST-O           B                  46 (III--V)      31                          67% (31/46)     100% (31/31)    100% (29/29)    Surgical cases excluded; AAST-O with modifications used
  Total (95% CI)                 NA             NA                                       NA               NA                 NA               NA                          29% (17--42%)   51% (38--64%)   74% (61--85%)   

^a^, AAST equivalents of JAST grading used to define high--grade injuries ([@r6]). HGRT, high-grade renal trauma; AAST, the American Association for the Surgery of Trauma; AAST-O, original AAST grading \[1989\] ([@r4]); AAST-R, revised AAST grading \[2010\] ([@r5]); JAST, the Japanese Association for the Surgery of Trauma; B, blunt injury; P, penetrating injury; NA, not applicable; NS, not specified.

In 5 studies ([@r9],[@r15],[@r18],[@r20],[@r22]), rates of urinary extravasation were only available for patients with grade IV injuries and in 6 studies ([@r6],[@r10],[@r12],[@r13],[@r19],[@r26]) this rate was only available for grade IV--V injuries combined. The other studies included sufficient detail to calculate rates for different combinations of renal injury grades ([*Table 1*](#t1){ref-type="table"}). Incidence of urinary extravasation was 29% (95% CI: 17--42%) when all grade III--V injuries were combined, 74% (95%: CI: 61--85%) when only grade IV renal injuries were reported, and 51% (95% CI: 38--64%) when grades IV and V injuries were combined ([*Figure 2A,B,C*](#f2){ref-type="fig"}).

![Incidence of urinary extravasation after HGRT for AAST grades III--V (A), IV-only (B), and IV--V (C). HGRT, high-grade renal trauma; AAST, American Association for the Surgery of Trauma; ES, estimate.](tau-07-S2-S169-f2){#f2}

Rate of ureteral stenting for urinary extravasation
---------------------------------------------------

A total of 20 studies contained information to calculate rates of ureteral stenting for urinary extravasation. Five studies ([@r18],[@r20],[@r23],[@r29],[@r33]) were not included in the meta-analysis for stenting rates because of data overlap with other studies included in the analysis ([@r9],[@r13],[@r32]). [*Table 2*](#t2){ref-type="table"} summarizes the 15 studies included for calculating rate of ureteral stenting for urinary extravasation. Overall, 29% (95% CI: 22--36%) of patients with urinary extravasation received ureteral stenting either immediately or in a delayed fashion ([*Figure 3*](#f3){ref-type="fig"}).

###### Summary of studies reporting rates of ureteral stenting for urinary extravasation after HGRT

  Author year                    Trauma mechanism   No. urinary extravasation   No. stented (%)   Comment
  ------------------------------ ------------------ --------------------------- ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Keihani *et al.* 2018          B & P              72                          17 (24%)          Multi-institutional data from the Genito-Urinary Trauma Study Group; only patients with CT scans available for review were included in the analysis
  Winters *et al.* 2016          B & P              95                          27 (28%)          Routine follow-up CT scan at 48 h and prophylactic stenting if persistent or worsening leak. Grade V injuries were excluded
  Shaaban *et al.* 2016          B & P              16                          1 (6%)            
  May *et al.* 2016              B                  3                           1 (33%)           
  Lanchon *et al.* 2016          B                  96                          29 (30%)          Retrograde ureteral stent placement was performed secondarily in patients with symptomatic ureteral clot obstruction or significant urine leakage on subsequent CT
  Baghdanian *et al.* 2016       B                  22                          11 (50%)          High rates of delayed diagnosis and intervention for urinary extravasation (50% missed at the initial imaging)
  Parkash *et al.* 2015          B                  15                          9 (60%)           Treatment protocol of strict bed rest until resolution of gross hematuria, prophylactic antibiotics, and close monitoring; all patients underwent follow-up CT scan after 48 h. Grade V injuries excluded
  Fischer *et al.* 2015          B & P              26                          12 (46%)          About half of the patients did not undergo excretory phase imaging; number of urinary extravasation may be underestimated
  Van der Wilden *et al.* 2013   B                  60                          24 (40%)          Multi-institutional data; about half the stentings were performed for delayed complications
  Hardee *et al.* 2013           B & P              21                          9 (43%)           Includes three ureteral injuries; delayed urinary extravasation identified in 7 patients without initial excretory phase imaging
  Smith *et al.* 2010            B                  81                          16 (20%)          
  Malcolm *et al.* 2008          B                  7                           3 (42%)           3 delayed stenting for persistent urinary extravasation; one patients upgraded to grade IV after follow-up imaging
  Alsikafi *et al.* 2006         B & P              34                          3 (9%)            Non-operative management included bed rest until resolution of gross hematuria, broad spectrum antibiotics; routine follow-up CT scan at 3--7 days after injury; patients with persistent urinary extravasation received stents
  Moudouni *et al.* 2001         B                  20                          5 (25%)           Management included bed rest until resolution of gross hematuria, broad spectrum antibiotics, and close monitoring
  Haas *et al.* 1998             B                  31                          5 (16%)           Management included bed rest until resolution of gross hematuria, broad spectrum antibiotics, and close follow-up with appropriate radiographic studies
  Total (95% CI)                 NA                 NA                          28% (21--36%)     

HGRT, high-grade renal trauma; B, blunt injury; P, penetrating injury.

![Rates of ureteral stenting after HGRT. HGRT, high-grade renal trauma; ES, estimate.](tau-07-S2-S169-f3){#f3}

Discussion
==========

Most estimations on the incidence of urinary extravasation and ureteral stenting after renal trauma are inferred from few studies with small sample sizes. This study pools the results from multiple studies and the findings provide a more comprehensive estimate for urinary extravasation and ureteral stenting. In our meta-analysis, urinary extravasation was diagnosed in about 30% of HGRT (defined as AAST grade III to V). This rate was naturally higher (51%) when only grade IV and V injuries were considered. In our pooled analysis, about 29% of patients with urinary extravasation after HGRT underwent ureteral stenting.

True incidence of urinary extravasation after HGRT is difficult to estimate due to the limitations of the current evidence. Studies are usually small and from single institutions, and the definitions and grading systems used in different studies are inconsistent. Accurate diagnosis of urinary extravasation requires obtaining abdomen/pelvis CT scans with a delayed excretory phase as recommended by the American Urological Association (AUA) urotrauma guidelines ([@r34]). Many of the patients who present in shock or undergo immediate laparotomy do not have a pre-operative CT scan available. Additionally, excretory phase images are not always obtained in trauma patients as the compliance with these imaging recommendations are variable even in level-1 trauma centers ([@r21]). As a result, we observed a wide range for incidence of urinary extravasation between studies in our analysis (e.g., range of 6.5--67% for grade III--V injuries). It could be argued that pooling the results for grade III--V injuries add little additional information as by definition grade III injuries do not include collecting system injuries, and presence of urinary extravasation would upgrade the injury to grade IV. However, in real practice, many patients do not undergo initial delayed phase imaging---which is necessary for accurate grading---and some injuries are initially classified as grade III until complications arise or adequate imaging is performed. Thus, rates of urinary extravasation after HGRT (which includes grade III) provides a better estimation of the prevalence and burden of urinary extravasation after HGRT and calls for prospective trials to study optimal management of this condition.

When considering grade IV injuries, we found a 74% rate of urinary extravasation. Renal injuries are graded as IV either when there is a large laceration leading to collecting system injuries or when specific vascular injuries are present. As expected, most grade IVs are based on the hallmark of collecting system laceration; however, variations in grading definitions can lead to over- or under-estimation of the proportion of grade IV patients with urinary extravasation. For example, in some studies, the authors used adaptations of the AAST grading by dropping the vascular component of grade IV classification ([@r29]). This essentially makes all grade IV injuries collecting system lacerations (i.e., 100% rate of urinary extravasation for grade IV). However, based on the proposed revised AAST classification ([@r5]), about 60% of grade IV injuries are collecting system lacerations while another 40% are segmental vascular injuries ([@r9]). Thus, a grade IV injury is not equivalent to having urinary extravasation and reporting injury specifics is required for a better understanding of injury patterns and management protocols.

Guidelines for management of urinary extravasation after renal injury are not well established. It is widely believed that most cases of urinary extravasation---as high as 76% to 90%---will heal spontaneously and without any intervention ([@r29]-[@r31]). Endoscopic ureteral stenting has been recommended for cases of persistent or progressive extravasation, which was estimated to occur in 13--26% of patients with urinary extravasation ([@r35]). The observed rates of stenting in our meta-analysis (29%, 95% CI: 22--36%) suggests higher rates of ureteral stent use for urinary extravasation; however, it remains unknown in what fraction of patients ureteral stenting could be avoided and how many patients actually underwent stenting due to complications. The variation in ureteral stenting rates largely depends upon clinicians' beliefs about the best management for urinary extravasation and there are likely significant variations in management protocols at different centers ([@r21]). For example, in a survey by Yeung *et al.*, trauma surgeons were more likely to opt for early stenting for urinary extravasation, while urologists had a higher threshold for intervention and usually relied on follow-up imaging and clinical symptoms ([@r36]).

Several theoretical concerns arise with overuse of ureteral stents. One concern is that endoscopic procedures may potentially contaminate perinephric collections and increase the risk of infected hematoma or urinoma. Also, ureteral stents are generally used by urologists to bypass obstructions such as a ureteral stricture or calculi. While blood clots may obstruct the kidney and encourage urinary extravasation, in many circumstance, there is an axiomatic but potentially false belief that a stent will increase urinary flow out of the kidney. In fact, the ureter is designed to maximize flow with its peristaltic action and may be far better at emptying the kidney compared to a stent in place ([@r37]).

This study has several limitations. There is obvious selection bias in the included studies; i.e., emergency operative cases and those that did not have appropriate imaging studies were excluded from most studies which can lead to underestimation of urinary extravasation rates, as these patients usually have more severe injuries. Information on percutaneous nephrostomy was not provided in the screened articles, thus the actual rates of renal drainage for urinary extravasation may be higher. Additionally, most included studies are from high-volume level-1 trauma centers which are known to use expectant management at a higher rate compared to lower tier trauma center. Thus, the 29% rate of ureteral stenting might be an underestimation. However, better understanding of this incidence is important for urologists treating HGRT and highlights the importance of prospective trials to study management of urinary extravasation. Another limitation is that the pooled results, in our study, span decades of care during which diagnosis and management of renal trauma has considerably changed; so some rates from older studies may not be applicable to current management of urinary extravasation. Last but not least, the protocols and indications for ureteral stenting are not well-defined in urotrauma guidelines so physician and center preferences no doubt significantly affected the rates in different studies.

Conclusions
===========

The incidence of urinary extravasation after high grade renal trauma was 29% (95% CI: 17--42%) for grade III--V injuries, 51% (95% CI: 38--64%) for grades IV and V, and 74% (95% CI: 61--85%) for grade IV renal injuries. The rate of ureteral stenting in patients with urinary extravasation was 29% (95% CI: 22--36%). Understanding these rates are essential as a first step for designing prospective trials to evaluate the utility and timing of ureteral stenting in the treatment of urinary extravasation after renal trauma.

Methodology
===========

We referred to Scoping Review (ScR) methodology per Arksey and O'Malley and The Joanna Briggs Institute Methodology for Scoping Reviews for this investigation ([@r3],[@r38]). As a method of evidence synthesis, the ScR is useful to identify and characterize (or map) a body of literature rather than answer a focused question of effectiveness---as do Systematic Reviews of effectiveness; and unlike the Systematic Reviews where all criteria and methods are specified a priori, the ScR allows for post-hoc decision making. Additionally, scoping reviews do not typically include quality assessment of the included studies. Given that the incidence of urinary extravasation is poorly reported, diagnosis is difficult, and management is not supported by evidence-based guidelines, the ScR approach suited the intention of this review---to provide a limited meta-analysis and narrative synthesis of incidence, diagnosis and management of urinary extravasation.

Inclusion criteria
==================

All of the following criteria were required for inclusion:

1.  ❖ Adults 16 years and older;

2.  ❖ High grade renal trauma defined using the American Association for the Surgery of Trauma (AAST) grading ([@r4]) as grades III--V (or equivalent);

3.  ❖ Patients with diagnosed urinary extravasation (for calculation of incidence of urinary extravasation after high-grade renal trauma) or patients undergoing ureteral stenting for urinary extravasation (for calculation of rates of ureteral stenting after diagnosis of urinary extravasation);

4.  ❖ Published 1989 or later \[a post-literature search decision based on the publication date of the AAST grading system ([@r4])\].

Literature search
=================

Due to a lack of controlled vocabulary or keyword references (e.g., Medline MeSH terms) for urinary extravasation in the literature, a sensitive search strategy, focused on renal trauma was used. A strategy was developed for OVID Medline, peer reviewed and then translated for the following databases: CINAHL (Ebsco), Cochrane Library (Wiley), and Embase.com. We also ran a keyword search in a collection of full-text journals via OVID, and checked reference lists of included or related studies. We used no language, methodological (study design), or date limits for the initial search. EndNote X7 software (Clarivate Analytics, Boston, MA, USA) was used to manage and deduplicate references.

Study selection
===============

Title, abstract and full-text screening were conducted independently by two reviewers with disagreements resolved by consensus or a third reviewer. A PRISMA flow diagram on the screening and inclusion steps is available in the manuscript ([*Figure 1*](#f1){ref-type="fig"}).

Data extraction
===============

Data extraction was conducted by both reviewers. A data extraction form was developed in Excel and is available at the end of this document. When multiple studies from the same center with data overlap were available, we used data from the most recent study and used other reports to extract data not available in the most recent publication if needed. The following information was recorded for each included study:

1.  ❖ Citation;

2.  ❖ Language;

3.  ❖ Study aim;

4.  ❖ Study design;

5.  ❖ Setting;

6.  ❖ Study duration;

7.  ❖ Timing of data collection;

8.  ❖ Grade of renal trauma and instrument/system used;

9.  ❖ Type of renal trauma (blunt, penetrating, both);

10. ❖ Total number of patients;

11. ❖ Patients diagnosed with urinary extravasation;

12. ❖ Patients treated with ureteral stenting for urinary extravasation;

13. ❖ Management strategy used (other than ureteral stenting);

14. ❖ Complications (if reported);

Data synthesis
==============

Collected data, as well as the results from our literature search was used to identify knowledge gaps in incidence, diagnosis, and management of urinary extravasation after renal trauma. We calculated rates for ureteral stenting only when it was reported, because procedures such as nephrostomy tube and peri-renal drain placement, as well as open surgeries, were inconsistently reported, thus making it impossible to calculate meaningful rates of intervention for these procedures. Complication data was also rarely and inconsistently reported in individual studies and were not used for our analyses.

Incidence of urinary extravasation was calculated based on the extracted values for each study. The rates of urinary extravasation had to be reported differently based upon whether studies reported urinary extravasation rates in populations of grades III--V, IV-only, or IV--V. Rate of ureteral stenting was calculated in patients diagnosed with urinary extravasation. A meta-analysis of single sample binary proportions was performed using a random-effects model with the DerSimonian and Laird method ([@r39]). The pooled estimate was calculated after applying the Freeman-Tukey double arcsine transformation to stabilize the variances. Confidence intervals (CIs) were computed using the exact binomial (Clipper-Pearson) method ([@r40]). The meta-analysis was performed using the *metaprop* command ([@r41]) using STATA-15 statistical software (Stata corp., College Station, TX, USA).

Search strategy
===============

Database: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) (1946 to present).

Search strategy:

1.  Acute Kidney Injury/or Kidney/in (41274)

2.  *(kidney or renal) adj3 (injury or injuries or wound? or trauma?)*. *ti*,*ab*,*kw*,*kf*. *(30148)*

3.  *(acute or major or sever\$) adj2 (kidney or renal) adj2 (injury or injuries or wound? or trauma?)*. *ti*,*ab*,*kw*,*kf*.*(14181)*

4.  *(blunt or highgrade or high*-*grade or penetrat\$ or nonpenetrat\$ or non*-*penetrat\$) adj2 (kidney or renal)*. *ti*,*ab*,*kw*,*kf*. *(643)*

5.  *(Grade 3 or Grade III or Grade 4 or Grade IV or Grade 5 or Grade V or 3rd grade or 4th grade or 5th grade) adj2 (kidney or renal)*. *ti*,*ab*,*kf*,*kw*. *(308)*

6.  *or/1*-*2*,*4*-*5 (Kidney Injury Set 1) (60921)*

7.  Kidney/ (253176)

8.  *(injury or injuries or trauma? or wound? or (Grade 3 or Grade III or Grade 4 or Grade IV or Grade 5 or Grade V or 3rd grade or 4th grade or 5th grade or highgrade or high grade))*.*ti*. *(357781)*

9.  *((acute or blunt or highgrade or high grade or major or non*-*penetrat\$ or penetrat\$ or sever\$) adj2 (injury or injuries or trauma?))*. *ti*,*ab*,*kw*,*kf*. *(103710)*

10. *((Grade 3 or Grade III or Grade 4 or Grade IV or Grade 5 or Grade V or 3rd grade or 4th grade or 5th grade) adj2 (injury or injuries or trauma? or wound?)*. *ab*,*kf*,*kw*. *(785)*

11. *(7 and (or/8*-*10)) not 6 (Kidney Injury*---*Set*: *2) (1443)*

12. *extravasat\$*.*ti*. *(2536)*

13. *\[Extravasat\$ adj2 (uret\$ or urol\* or urin\* or kidney or renal)\]*. *ab*,*kf*,*kw*. *(538)*

14. *or/12*-*13 (Extravasation*: *Set 3) (2971)*

15. *(leakage or leak or leaking or leaks) adj2 (uret\$ or urol\* or urin\* or kidney or renal)*. *ti*,*ab*,*kf*,*kw*. *(3026)*

16. *(ureteral or urinar\$ or urolog\$) adj2 drain\$*. *ti*,*ab*,*kw*,*kf*. *(1011)*

17. *or/15*-*16 (Urinary Leak/Drain*: *Set 4) (4000)*

18. Conservative Management/ (134)

19. *(conservativ\$ or management)*. *ti*. *(332107)*

20. *(conservat\$ adj2 (intervent\$ or manag\$ or therapy or therapies or treat\$)*. *ab*,*kw*,*kf*. *(57151)*

21. *(non*-*surg\$ or nonsurg\$ or less invasiv\$ or initial\$ or non*-*operat\$ or nonoperat\$ or organ sparing) adj3 (intervent\$ or manag\$ or treat\$))*. *ti*,*ab*,*kw*. *(73452)*

22. *{\[(revision or repeat\$) adj2 surg\$\] or reoperat\$}*. *ti*,*ab*,*kw*,*kf*. *(44871)*

23. Reoperation/ (74802)

24. *or/18*-*23 (Management) (534573)*

25. *Nephrostomy*, *Percutaneous/ (4199)*

26. *(Nephrostom\$ or Nephrolithotomy or Nephrolithotomies)*. *ti*,*ab*,*kw*,*kf*. *(6297)*

27. *or/25*-*26 (Nephrostomy) (7626)*

28. *\[(uret\$ or urolog\$ or urin\$) adj2 stent\$\]*. *ti*,*ab*,*kw*,*kf*. *(3682)*

29. *(drain\$ adj3 tube?)*. *ti*,*ab*,*kw*,*kf*. *(4973)*

30. *or/28*-*29 (Urin Stent or Drain) (8628)*

31. Kidney/in and (Urogenital System/ or Urinary Bladder/ or Urinary Tract/) (238)

32. Kidney/ and (Urogenital System/in or Urinary Bladder/in or Urinary Tract/in) (233)

33. *(Kidney/ or Acute Kidney Injury/) and (Urogenital System/ or Urinary Bladder/ or Urinary Tract/) and ((injury or injuries? or wound? or trauma? or symptom?)*. *ti*,*ab*,*kw*,*kf*. *or (injuries or therapy)*.*fs*.*) (579)*

34. *(kidney*.*ti*. *or Kidney/ or Acute Kidney Injury/) and ("wounds and injuries"/ or Wounds*, *Penetrating/ or Wounds*, *Nonpenetrating/ or Wounds*, *Gunshot/ or Wounds*, *Stab/) (2024)*

35. *or/31*-*34 (Kidney and Urogenital & Injury) (2489)*

36. *\[extravasat\$ adj3 (kidney or renal)\]*. *ti*,*ab*,*kw*,*kf*.*(Keyword) (112)*

37. *or/6*,*11 (Kidney Injury) (62364)*

38. *and/14*,*37 (Kidney Injury & Extravasation*: *Results 1) (102)*

39. *(and/17*,*37) not 38 (Kidney Injury & Urinary Leakage*: *Results 2) (106)*

40. *(and/24*,*37) not (or/38*-*39) (Kidney Injury & Management*: *Results 3) (2343)*

41. *(and/27*,*37) not (or/38*-*40) (Kidney Injury & Nephrostomy*: *Results 4) (216)*

42. *(and/30*,*37) not (or/38*-*41) (Kidney Injury & Urinary Stent/Drain*: *Results 5) (62)*

43. *35 not (or/38*-*42) (Kidney & Urogenital etc*. *Injury*: *Results 6) (1967)*

44. *36 not (or/38*-*43) (Results Set 7) (86)*

45. animal/ not (animal/ and human/) (Animals MeSH) (4293926)

46. *(animal? or beaver? or beef or bovine or breeding or bull or canine or castoris or cat or cattle or cats or chicken? or chimp\$ or cow or dog or dogs or equine or foal or foals or fish or insect? horse or horses or livestock or mice or monkey? or mouse or murine or plant or plants or pork or porcine or protozoa? or purebred or rat or rats or rodent? or sheep or thoroughbred)*.*ti*. *or veterinar\$*. *ti*,*ab*,*kw*,*kf*,*hw*. *(2112064)*

47. *or/45*-*46 \[Animal Filter\] (4775151)*

    1.  48*. (or/38*-*44) not 47 (All Results) (4616)*

        1.  remove duplicates from 48 (4578)

Data extraction sheet
=====================

Scoping review title.

A. General information:

  -------------------------------------- --
  1\. Date form completed (dd/mm/yyyy)   
  2\. Name of person extracting data     
  3\. Paper title                        
  4\. First author-year                  
  5\. Record number (From EndNote)       
  6\. Notes                              
  -------------------------------------- --

B. Eligibility:

A study is eligible if:

I.  Population study includes adults regardless of sex;

II. The study clearly indicates the number of high-grade renal injuries (defined as AAST grades III--V or IV--V or IV or OIS equivalent);

III. The study reports on number of patients diagnosed with urinary extravasation so an incidence of patients with urinary extravasation can be calculated (based on CT-scans, exclude if only IVP is used);

IV. Inclusion for management part: the study mentions number of patients with urinary extravasation and the number who were managed with stenting (Note: only procedures specific for management of urinary extravasation will be included, and not those for bleeding or nonspecific).

Do not proceed if study excluded from review.

C. Population and setting:

                                                     Description
  -------------------------------------------------- -------------
  Type of study (e.g., retrospective, prospective)   
  Study location and setting (city, country)         
  Start date \-- End date                            
  Duration of participation                          
  Notes                                              

D. Participants:

                                                                                                          Description
  ------------------------------------------------------------------------------------------------------- -------------
  Total No. of participants                                                                               
  Trauma types (blunt, penetrating, both)                                                                 
  No. of HGRT (please indicate the grades defined as high-grade)                                          
  Grading system used (original 1989 AAST, Revised 2011 AAST, Other- specify)                             
  No. of renal injuries based on grades                                                                   
     AAST III                                                                                             
     AAST IV                                                                                              
     AAST V                                                                                               
  No. patients with urinary extravasation                                                                 
  Percentage of high grade renal trauma with urinary extravasation (specify the denominator and grades)   
  Notes                                                                                                   

E. Interventions & outcomes for urinary extravasation: (e.g., rhinorrhaphy or nephrectomy for bleeding is not relevant here):

                                                                                  Description
  ------------------------------------------------------------------------------- -------------
  Management options listed in the study for urinary extravasation                
  No. of patients treated conservatively                                          
  No. of patients received immediate/delayed stenting                             
  No. of patients with percutaneous nephrostomy                                   
  No. of patients with peri-renal drain (if mentioned)                            
  No. of patients needing renorrhaphy for urin.extrav (if mentioned)              
  No. of patients needing partial nephrectomy for urin.extrav (if mentioned)      
  No. of patients needing nephrectomy for urin.extrav (if mentioned)              
  Notes (please explain how the study reports extravasation and its management)   

Complications and follow-up specific for urinary extravasation:

                               Description
  ---------------------------- -------------
  No. of urinomas (and%)       
  No. of other complications   
  Notes:                       

Final decision
==============

Please indicate if this study will be included in the final table for the manuscript.

Explain the reason for exclusion after full-review.
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